Global Oncology Research

Access to Novel Treatments & Clinical Trials

When standard treatments are exhausted, innovation offers a new path forward. As a GCP-certified Principal Investigator, Dr. Manish Tiwari provides eligible patients exclusive access to groundbreaking Phase I-III global clinical trials, delivering tomorrow's targeted therapies today.

Dr Manish Tiwari Principal Investigator Clinical Trials

Recurrent Malignancies

Cancers that have stubbornly returned despite aggressive surgery or radiation, requiring novel approaches.

Exhausted Standard Care

Patients who have completed all traditional lines of chemotherapy and immunotherapy without success.

Advanced Staging

Metastatic or locally advanced (Stage IV) tumors where conventional surgery is no longer an option.

Specific Biomarkers

Patients with specific genetic mutations (like EGFR positive) seeking highly targeted molecular therapies.

Understanding Clinical Research

What Are Phase I-III Trials?

Clinical trials are heavily regulated, meticulously monitored medical studies that test the safety and effectiveness of new drugs, surgical devices, or therapies before they are widely available to the general public.

Phase I: Safety & Dosage

The first step in human testing. These trials involve a small group of patients and focus primarily on establishing the safest dose of a new drug and identifying any immediate side effects.

  • First-in-class novel therapies
  • Intense, highly personalized monitoring

Phase II: Efficacy Focus

Once a safe dose is determined, Phase II trials expand to a larger group of patients. The goal shifts to evaluating how effectively the new therapy shrinks tumors or halts cancer progression.

  • Targeted approach for specific cancers
  • Access to promising immunological agents

Phase III: The New Standard

Large-scale global studies that compare the new, experimental therapy directly against the current "gold standard" treatment to prove it is superior or has fewer side effects.

  • Often leads to FDA/global approval
  • High probability of therapeutic benefit
The Protocol

The Enrollment Pathway

Participation is strictly voluntary and governed by stringent international ethics boards (IRB/IEC) to prioritize your safety above all else.

01

Rigorous Screening

We conduct advanced genomic sequencing, blood work, and PET scans to see if your specific tumor biology perfectly matches the requirements of an active trial.

02

Informed Consent

Our dedicated trial coordinators explain every detail, potential risk, and expected benefit, ensuring you have total control and understanding before proceeding.

03

Active Treatment & Surveillance

You receive the novel therapy under the direct, constant supervision of Dr. Tiwari's team, with far more frequent check-ups and scans than standard care.

Clinical Trial Research Scientist

Safety & Patient Value

Why Participate?

Clinical trials offer opportunities that simply do not exist in standard medical pathways.

  • Early Access: Receive cutting-edge drugs or technologies years before they are available in pharmacies.
  • Elite Medical Attention: Trial patients are monitored by a dedicated team of research coordinators, nurses, and principal investigators.
  • Financial Assistance: In many trials, the experimental drugs and associated trial-specific testing are provided at no cost to the patient.

Uncompromising Ethics & Safety

Your safety and autonomy are protected by international law and strict medical oversight.

  • GCP Certified: Dr. Tiwari and his team hold Good Clinical Practice (GCP) certifications, ensuring global standards are met.
  • IRB Oversight: Every trial is independently reviewed and approved by an Institutional Review Board to protect patient rights.
  • Right to Withdraw: You can choose to leave a clinical trial at any time, for any reason, without it affecting your standard medical care.
Accessible Premium Care

Conducted at Elite Research Facilities

Charnock Hospital
Desun Hospital
HCG, Newtown
Woodland, Alipore